PKD Educational Series - Listen to the Experts

PKD Educational Series

Join our renowned experts as they discuss and share their experience in autosomal dominant polycystic kidney disease (ADPKD) management in this learning series.

Themes & Objectives

  • Discover the most common manifestations of ADPKD and the role of genetic testing 
  • Reflect on the past, present, and future of ADPKD management
  • Identify patients with ADPKD for whom tolvaptan may be appropriate
  • Recognize the role of V2 receptor signaling pathways 

  • Jordan Weinstein

    MD, FRCPC

    Associate Professor of Medicine,
    University of Toronto
    Nephrologist,
    St. Michael’s Hospital
    Founder & Director,
    UKidney.com
    Toronto, ON

  • Daniel Bichet

    MD, FRCP(C), FACP

    Professor of Medecine, Pharmacology and Physiology,
    l’Université de Montréal
    Nephrologist, Hôpital du Sacré-Cœur de Montréal
    Montréal, QC

  • Arlene Chapman

    MD

    Professor of Medicine, Department of Medicine,
    Section Chief, Nephrology, Department of Medicine,
    Director of Clinical Resource Center, University of Chicago
    Chicago, IL, USA

  • York Pei

    MD, FRCP(C), FACP

    Senior Scientist,
    Toronto General Hospital Research Institute (TGHRI)
    Professor of Medicine, University of Toronto
    Nephrologist,
    Toronto General Hospital, University Health Network
    Toronto, ON

  • Vicente E. Torres

    MD, PhD

    Director,
    Mayo Clinic Translational Polycystic Kidney Disease (PKD) Center
    Consultant,
    Division of Nephrology & Hypertension, Department of Internal Medicine
    Rochester, MN, USA


    This program has received an educational grant or in-kind resources from Otsuka Canada Inc

    ukidneyisup